Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cindy Sanders

6PUBLICATIONS

31CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 01, 2024

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.

Bowen Dong, Nataša Obermajer, Takemasa Tsuji

|Nov 10, 2022

TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.

Pattra Chun-On, Angela M Hinchie, Holly C Beale

|Mar 23, 2021

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Yana G Najjar, Dustin McCurry, Huang Lin

|Jun 28, 2020

IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.

Joe-Marc Chauvin, Mignane Ka, Ornella Pagliano

|Dec 21, 2018

Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gα<sub>q</sub> and Gα<sub>11</sub> and kill uveal melanoma cells.

Laurence Booth, Jane L Roberts, Cindy Sander

|Dec 09, 2017

The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.

Laurence Booth, Jane L Roberts, Andrew Poklepovic

Pageof 1

Frequent Collaborators

4 joint publications

John M Kirkwood

2 joint publications

Diwakar Davar

1 joint publications

Huang Lin

1 joint publications

Rogerio I Neves

1 joint publications

Lisa H Butterfield

1 joint publications

Jehovana O Bender

1 joint publications

Christian Laing

1 joint publications

Pattra Chun-On

1 joint publications

Angela M Hinchie

1 joint publications

Holly C Beale

Frequent Collaborators

4 joint publications

John M Kirkwood

2 joint publications

Diwakar Davar

1 joint publications

Huang Lin

1 joint publications

Rogerio I Neves

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on : Apr 13, 2015

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on : Apr 13, 2015

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos